Skip to main content

Advertisement

Log in

Nociplastic pain concept, a mechanistic basis for pragmatic approach to fibromyalgia

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Nociplastic pain (NP), as a mechanistic term, denotes pain arising from altered nociception without clear evidence of tissue or somatosensory damage. Fibromyalgia (FM), a prototypical NP condition, incorporates a broad continuum of phenotypes with a distinct neurobiological signature and shared NP attributes. The nociplastic concept may provide a new opportunity for early diagnosis of FM by identifying the characteristic NP features before a state of pain generalization and symptoms clustering. In this approach, even individual symptoms associated with NP features are worthy of attention to denote FM. It may provide a timely diagnosis of FM before clinical progression to a severe and hard-to-manage condition. Furthermore, collecting all various FM phenotypes under the nociplastic concept and not delimiting FM to the only typical presentation allows investigators to identify FM subgroups reflecting potentially distinct pathophysiologic mechanisms and biomarkers. This viewpoint can be served in future studies to develop individualized management. In this review, we postulate a novel approach to early FM diagnosis and management based on NP conceptualization and phenotype recognition.

Key Points

FM as a NP condition represents overlapping clinical phenotypes and incomplete presentations especially in early stage of illness.

The mechanistic approach based on the NP features of FM can be implicated in the timely diagnosis and management of FM.

The NP-based approach to FM provides a broader viewpoint beyond FM delimitation to pain generalization and polysymptomatic complaints.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Winfried Häuser, Jacob Ablin, … Brian Walitt

References

  1. Kosek E, Cohen M, Baron R, Gebhart GF, Mico JA, Rice ASC et al (2016) Do we need a third mechanistic descriptor for chronic pain states? Pain 157(7):1382–1386

    Article  PubMed  Google Scholar 

  2. Trouvin AP, Perrot S (2019) New concepts of pain. Best Pract Res Clin Rheumatol 33(3):101415

    Article  PubMed  Google Scholar 

  3. Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Häuser W (2021) Nociplastic pain: towards an understanding of prevalent pain conditions. Lancet 397(10289):2098–2110

    Article  PubMed  Google Scholar 

  4. Kosek E, Clauw D, Nijs J, Baron R, Gilron I, Harris RE et al (2021) Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain 162(11):2629–2634

    Article  PubMed  Google Scholar 

  5. Bidari A, Ghavidel Parsa B, Ghalehbaghi B (2018) Challenges in fibromyalgia diagnosis: from meaning of symptoms to fibromyalgia labeling. The Korean journal of pain 31(3):147–154

    Article  PubMed  PubMed Central  Google Scholar 

  6. Häuser W, Sarzi-Puttini P, Fitzcharles MA (2019) Fibromyalgia syndrome: under-over- and misdiagnosis. Clin Exp Rheumatol 37(Suppl 116(1)):90–7

    PubMed  Google Scholar 

  7. Häuser W, Fitzcharles M-A (2018) Facts and myths pertaining to fibromyalgia. Dialogues Clin Neurosci 20(1):53–62

    Article  PubMed  PubMed Central  Google Scholar 

  8. Maixner W, Fillingim RB, Williams DA, Smith SB, Slade GD (2016) Overlapping chronic pain conditions: implications for diagnosis and classification. J Pain 17(9 Suppl):T93-t107

    Article  PubMed  PubMed Central  Google Scholar 

  9. Sarzi-Puttini P, Giorgi V, Marotto D, Atzeni F (2020) Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment. Nat Rev Rheumatol 16(11):645–660

    Article  PubMed  Google Scholar 

  10. Ghavidel-Parsa B, Bidari A, Tohidi S, Shenavar I, Kazemnezhad Leyli E, Hosseini K et al (2021) Implication of invalidation concept in fibromyalgia diagnosis. Clin Rheumatol 40(6):2369–2376

    Article  PubMed  Google Scholar 

  11. Sluka KA, Clauw DJ (2016) Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience 338:114–129

    Article  CAS  PubMed  Google Scholar 

  12. Clauw D (2021) Time to stop the fibromyalgia criteria wars and refocus on identifying and treating individuals with this type of pain earlier in their illness. Arthritis Care Res (Hoboken) 73(5):613–616

    Article  Google Scholar 

  13. Arnold LM, Bennett RM, Crofford LJ, Dean LE, Clauw DJ, Goldenberg DL et al (2019) AAPT diagnostic criteria for fibromyalgia. J Pain 20(6):611–628

    Article  PubMed  Google Scholar 

  14. Wolfe F, Walitt B (2013) Culture, science and the changing nature of fibromyalgia. Nat Rev Rheumatol 9(12):751–755

    Article  PubMed  Google Scholar 

  15. Ghavidel-Parsa B, Bidari A (2021) Two sides on the fibromyalgia coin: physical pain and social pain (invalidation). Clin Rheumatol 40(3):841–848

    Article  PubMed  Google Scholar 

  16. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL et al (1990) The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33(2):160–72

    Article  CAS  PubMed  Google Scholar 

  17. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P et al (2010) The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62(5):600–610

    Article  Google Scholar 

  18. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RS et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 38(6):1113–1122

    Article  PubMed  Google Scholar 

  19. Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Häuser W, Katz RL et al (2016) 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 46(3):319–329

    Article  PubMed  Google Scholar 

  20. Habib G, Sakas F, Khazin F (2021) Initial presentation of pain in patients with fibromyalgia. Isr Med Assoc J 23(9):576–579

    PubMed  Google Scholar 

  21. Harte SE, Harris RE, Clauw DJ (2018) The neurobiology of central sensitization. J Appl Biobehav Res 23(2):e12137

    Article  Google Scholar 

  22. Kindler LL, Jones KD, Perrin N, Bennett RM (2010) Risk factors predicting the development of widespread pain from chronic back or neck pain. J Pain 11(12):1320–1328

    Article  PubMed  PubMed Central  Google Scholar 

  23. Choy E, Perrot S, Leon T, Kaplan J, Petersel D, Ginovker A et al (2010) A patient survey of the impact of fibromyalgia and the journey to diagnosis. BMC Health Serv Res 10(1):102

    Article  PubMed  PubMed Central  Google Scholar 

  24. Kool MB, van Middendorp H, Boeije HR, Geenen R (2009) Understanding the lack of understanding: invalidation from the perspective of the patient with fibromyalgia. Arthritis Rheum 61(12):1650–1656

    Article  PubMed  Google Scholar 

  25. Santiago MG, Marques A, Kool M, Geenen R, da Silva JAP (2017) Invalidation in patients with rheumatic diseases: clinical and psychological framework. J Rheumatol 44(4):512–518

    Article  PubMed  Google Scholar 

  26. Homma M, Ishikawa H, Kiuchi T (2018) Illness perceptions and negative responses from medical professionals in patients with fibromyalgia: association with patient satisfaction and number of hospital visits. Patient Educ Couns 101(3):532–540

    Article  PubMed  Google Scholar 

  27. Ghavidel-Parsa B, Bidari A, Amir Maafi A, Ghalebaghi B (2015) The iceberg nature of fibromyalgia burden: the clinical and economic aspects. Korean J Pain 28(3):169–176

    Article  PubMed  PubMed Central  Google Scholar 

  28. Duque L, Fricchione G (2019) Fibromyalgia and its new lessons for neuropsychiatry. Med Sci Monit Basic Res 25:169–178

    Article  PubMed  PubMed Central  Google Scholar 

  29. Ghavidel-Parsa B, Bidari A, Atrkarroushan Z, Khosousi MJ (2021) Implication of the nociplastic features for clinical diagnosis of fibromyalgia: development of the preliminary nociplastic-based fibromyalgia features (NFF) tool. ACR Open Rheumatol

  30. Häuser W, Perrot S, Clauw DJ, Fitzcharles MA (2018) Unravelling fibromyalgia-steps toward individualized management. J Pain 19(2):125–134

    Article  PubMed  Google Scholar 

  31. Häuser W, Ablin J, Fitzcharles MA, Littlejohn G, Luciano JV, Usui C et al (2015) Fibromyalgia Nat Rev Dis Primers 1:15022

    Article  PubMed  Google Scholar 

  32. Bidari A, Ghavidel-Parsa B, Ghalehbaghi B (2009) Reliability of ACR criteria over time to differentiate classic fibromyalgia from nonspecific widespread pain syndrome: a 6-month prospective cohort study. Mod Rheumatol 19(6):663–669

    Article  PubMed  Google Scholar 

  33. Walitt B, Katz RS, Bergman MJ, Wolfe F (2016) Three-quarters of persons in the US population reporting a clinical diagnosis of fibromyalgia do not satisfy fibromyalgia criteria: the 2012 National Health Interview Survey. PLoS ONE 11(6):e0157235

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  34. Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F (2015) The prevalence and characteristics of fibromyalgia in the 2012 National Health Interview Survey. PLoS ONE 10(9):e0138024

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Wolfe F, Brähler E, Hinz A, Häuser W (2013) Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: results from a survey of the general population. Arthritis Care Res (Hoboken) 65(5):777–785

    Article  Google Scholar 

  36. Vincent A, Hoskin TL, Whipple MO, Clauw DJ, Barton DL, Benzo RP et al (2014) OMERACT-based fibromyalgia symptom subgroups: an exploratory cluster analysis. Arthritis Res Ther 16(5):463

    Article  PubMed  PubMed Central  Google Scholar 

  37. Seifert O, Baerwald C (2019) Impact of fatigue on rheumatic diseases. Best Pract Res Clin Rheumatol 33(3):101435

    Article  PubMed  Google Scholar 

  38. Apkarian AV, Baliki MN, Geha PY (2009) Towards a theory of chronic pain. Prog Neurobiol 87(2):81–97

    Article  PubMed  Google Scholar 

  39. Flor H, Birbaumer N, Turk DC (1990) The psychobiology of chronic pain. Adv Behav Res Ther 12(2):47–84

    Article  Google Scholar 

  40. Diers M (2019) Neuroimaging the pain network - implications for treatment. Best Pract Res Clin Rheumatol 33(3):101418

    Article  PubMed  Google Scholar 

  41. Wallrath MK, Rubel J, Ohls I, Demiralay C, Hechler T (2020) Bottom-up or top-down?: the role of child and parent chronic pain and anxiety in the context of parental catastrophizing and solicitousness. Eur J Pain 24(3):604–616

    Article  PubMed  Google Scholar 

  42. Villemure C, Bushnell CM (2002) Cognitive modulation of pain: how do attention and emotion influence pain processing? PAIN 95(3):195–199

    Article  PubMed  Google Scholar 

  43. Williams ACC, Craig KD (2016) Updating the definition of pain. Pain 157(11):2420–2423

    Article  PubMed  Google Scholar 

  44. Ellingson LD, Stegner AJ, Schwabacher IJ, Lindheimer JB, Cook DB (2018) Catastrophizing interferes with cognitive modulation of pain in women with fibromyalgia. Pain Med 19(12):2408–2422

    Article  PubMed  PubMed Central  Google Scholar 

  45. Sancassiani F, Machado S, Ruggiero V, Cacace E, Carmassi C, Gesi C et al (2017) The management of fibromyalgia from a psychosomatic perspective: an overview. Int Rev Psychiatry 29(5):473–488

    Article  PubMed  Google Scholar 

  46. Mayer TG, Neblett R, Cohen H, Howard KJ, Choi YH, Williams MJ et al (2012) The development and psychometric validation of the central sensitization inventory. Pain Pract 12(4):276–285

    Article  PubMed  Google Scholar 

  47. Perrot S, Bouhassira D, Fermanian J (2010) Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST). Pain 150(2):250–256

    Article  PubMed  Google Scholar 

  48. Bennett RM, Friend R, Marcus D, Bernstein C, Han BK, Yachoui R et al (2014) Criteria for the diagnosis of fibromyalgia: validation of the modified 2010 preliminary American College of Rheumatology criteria and the development of alternative criteria. Arthritis Care Res (Hoboken) 66(9):1364–1373

    Article  Google Scholar 

  49. Yunus MB (2008) Central sensitivity syndromes: a new paradigm and group nosology for fibromyalgia and overlapping conditions, and the related issue of disease versus illness. Semin Arthritis Rheum 37(6):339–352

    Article  PubMed  Google Scholar 

  50. Grayston R, Czanner G, Elhadd K, Goebel A, Frank B, Üçeyler N et al (2019) A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: implications for a new paradigm in fibromyalgia etiopathogenesis. Semin Arthritis Rheum 48(5):933–940

    Article  PubMed  Google Scholar 

  51. Egloff N, von Känel R, Müller V, Egle UT, Kokinogenis G, Lederbogen S et al (2015) Implications of proposed fibromyalgia criteria across other functional pain syndromes. Scand J Rheumatol 44(5):416–424

    Article  CAS  PubMed  Google Scholar 

  52. Kia S, Choy E (2017) Update on treatment guideline in fibromyalgia syndrome with focus on pharmacology. Biomedicines 5(2):20

    Article  PubMed Central  CAS  Google Scholar 

  53. Tzadok R, Ablin JN (2020) Current and emerging pharmacotherapy for fibromyalgia. Pain Res Manage 2020:6541798

    Article  Google Scholar 

  54. López-Solà M, Woo C-W, Pujol J, Deus J, Harrison BJ, Monfort J et al (2017) Towards a neurophysiological signature for fibromyalgia. Pain 158(1):34–47

    Article  PubMed  PubMed Central  Google Scholar 

  55. Gracely RH, Petzke F, Wolf JM, Clauw DJ (2002) Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 46(5):1333–1343

    Article  PubMed  Google Scholar 

  56. Giesecke T, Gracely RH, Grant MA, Nachemson A, Petzke F, Williams DA et al (2004) Evidence of augmented central pain processing in idiopathic chronic low back pain. Arthritis Rheum 50(2):613–623

    Article  PubMed  Google Scholar 

  57. Naliboff BD, Derbyshire SW, Munakata J, Berman S, Mandelkern M, Chang L et al (2001) Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation. Psychosom Med 63(3):365–375

    Article  CAS  PubMed  Google Scholar 

  58. Napadow V, LaCount L, Park K, As-Sanie S, Clauw DJ, Harris RE (2010) Intrinsic brain connectivity in fibromyalgia is associated with chronic pain intensity. Arthritis Rheum 62(8):2545–2555

    Article  PubMed  PubMed Central  Google Scholar 

  59. Seminowicz DA, Davis KD (2007) Pain enhances functional connectivity of a brain network evoked by performance of a cognitive task. J Neurophysiol 97(5):3651–3659

    Article  PubMed  Google Scholar 

  60. Apkarian AV, Sosa Y, Sonty S, Levy RM, Harden RN, Parrish TB et al (2004) Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci 24(46):10410–10415

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  61. Smallwood RF, Laird AR, Ramage AE, Parkinson AL, Lewis J, Clauw DJ et al (2013) Structural brain anomalies and chronic pain: a quantitative meta-analysis of gray matter volume. J Pain 14(7):663–675

    Article  PubMed  PubMed Central  Google Scholar 

  62. Lutz J, Jäger L, de Quervain D, Krauseneck T, Padberg F, Wichnalek M et al (2008) White and gray matter abnormalities in the brain of patients with fibromyalgia: a diffusion-tensor and volumetric imaging study. Arthritis Rheum 58(12):3960–3969

    Article  PubMed  Google Scholar 

  63. O’Mahony LF, Srivastava A, Mehta P, Ciurtin C (2021) Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis Rheumatology (Oxford) 60(6):2602–2614

    Article  CAS  Google Scholar 

  64. Theoharides TC, Tsilioni I, Bawazeer M (2019) Mast Cells, Neuroinflammation and pain in fibromyalgia syndrome. Front Cell Neurosci 13

  65. Albrecht DS, Forsberg A, Sandström A, Bergan C, Kadetoff D, Protsenko E et al (2019) Brain glial activation in fibromyalgia - a multi-site positron emission tomography investigation. Brain Behav Immun 75:72–83

    Article  PubMed  Google Scholar 

  66. Shraim MA, Massé-Alarie H, Hodges PW (2021) Methods to discriminate between mechanism-based categories of pain experienced in the musculoskeletal system: a systematic review. Pain 162(4):1007–1037

    Article  CAS  PubMed  Google Scholar 

  67. Nijs J, George SZ, Clauw DJ, Fernández-de-las-Peñas C, Kosek E, Ickmans K et al (2021) Central sensitisation in chronic pain conditions: latest discoveries and their potential for precision medicine. The Lancet Rheumatology 3(5):e383–e392

    Article  Google Scholar 

  68. López-Ruiz M, Losilla JM, Monfort J, Portell M, Gutiérrez T, Poca V et al (2019) Central sensitization in knee osteoarthritis and fibromyalgia: beyond depression and anxiety. PloS one 14(12):e0225836-e

    Article  CAS  Google Scholar 

  69. Cohen SP, Vase L, Hooten WM (2021) Chronic pain: an update on burden, best practices, and new advances. Lancet 397(10289):2082–2097

    Article  PubMed  Google Scholar 

  70. Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DLH, Bouhassira D et al (2016) Neuropathic pain: an updated grading system for research and clinical practice. Pain 157(8):1599–1606

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Ghavidel-Parsa B, Bidari A, Rahimi A, Gharibpoor F, Khosousi MJ (2021) No effect of approved fibromyalgia drugs on the social pain (invalidation) contrary to physical pain: an open-label short-term randomized clinical trial. Clin Rheumatol

  72. Häuser W, Jones G (2019) Psychological therapies for chronic widespread pain and fibromyalgia syndrome. Best Pract Res Clin Rheumatol 33(3):101416

    Article  PubMed  Google Scholar 

  73. Ryabkova VA, Churilov LP, Shoenfeld Y (2019) Neuroimmunology: what role for autoimmunity, neuroinflammation, and small fiber neuropathy in fibromyalgia, chronic fatigue syndrome, and adverse events after human papillomavirus vaccination? Int J Mol Sci 20(20)

  74. Malfliet A, Kregel J, Meeus M, Danneels L, Cagnie B, Roussel N et al (2018) Patients with chronic spinal pain benefit from pain neuroscience education regardless the self-reported signs of central sensitization: secondary analysis of a randomized controlled multicenter trial. Pm r 10(12):1330–43.e1

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Banafsheh Ghavidel-Parsa.

Ethics declarations

Disclosures

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bidari, A., Ghavidel-Parsa, B. Nociplastic pain concept, a mechanistic basis for pragmatic approach to fibromyalgia. Clin Rheumatol 41, 2939–2947 (2022). https://doi.org/10.1007/s10067-022-06229-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-022-06229-5

Keywords

Navigation